Keyphrases
Histone Deacetylase Inhibitor (HDACi)
100%
Doxorubicin
100%
Mammary Tumor
100%
Diethyl Phosphite
100%
AN-7
100%
Disparate Impact
100%
Myocardium
18%
H2AX
18%
RAD51
18%
Apoptosis
12%
Insults
12%
MRE11
12%
DNA Repair
6%
Fibrosis
6%
Expression Level
6%
High-level Expression
6%
Beneficial Effects
6%
Synergize
6%
Tumor Growth
6%
DNA Double-strand Breaks
6%
Cytochrome c (Cyt c)
6%
Cardioprotection
6%
C-kit
6%
C-Myc
6%
Molecular Analysis
6%
Anticancer Activity
6%
Heart Tissue
6%
Ki-67
6%
Lung Metastasis
6%
Cytotoxic Effect
6%
Cytochrome c Release
6%
Anti-HER2
6%
4T1 Tumor
6%
Doxorubicin Treatments
6%
Doxorubicin Toxicity
6%
Doxorubicin-induced Cardiomyopathy
6%
Mammary Carcinoma Cells
6%
Heart Tumor
6%
Tumor Fibrosis
6%
Tumor Levels
6%
Improved Anticancer Efficacy
6%
Pharmacology, Toxicology and Pharmaceutical Science
Mouse
100%
Histone Deacetylase Inhibitor
100%
Doxorubicin
100%
Breast Tumor
100%
Neoplasm
21%
Cytochrome C
10%
Fibrosis
10%
Tumor Growth
5%
Vasculotropin
5%
Lung Metastasis
5%
Cardiomyopathy
5%
Breast Carcinoma
5%
Double Stranded DNA
5%
Biochemistry, Genetics and Molecular Biology
Mouse
100%
Doxorubicin
100%
Histone Deacetylase
100%
Anticancer
10%
Cytochrome
10%
DNA Repair
5%
Cytotoxicity
5%
Tumor Progression
5%
Vascular Endothelial Growth Factor
5%
Oncogene C Myc
5%